Skip to main content
Back
Watch Compare

GOLDENWELL BIOTECH, INC.

Data quality: 100%
GWLL
OTC Manufacturing Food Products
$1.00
$0.00 (0.00%)
Mkt Cap: 99.35 M
Price
$1.00
Mkt Cap
99.35 M
Day Range
—
52-Week Range
—
Volume
—
Open —
50D / 200D Avg
—
50D / 200D Avg
—

Quick Summary

Key Takeaways

Net margin of 22481.65% shows strong profitability
Negative free cash flow of -22,832.0

Growth

Revenue Growth (5Y)
N/A
Revenue (1Y)-94.06%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Quality

Return on Equity
N/A
ROIC-25.94%
Net Margin22481.65%
Op. Margin38238.61%

Safety

Debt / Equity
N/A
Current RatioN/A
Interest Coverage-4.11

Valuation

PE (TTM)
-2796.84
Below sector avg (-1.47)
P/B RatioN/A
EV/EBITDAN/A
Dividend YieldN/A

Price History

Financial Trends

Peer Comparison

vs Manufacturing sector median (1364 peers)
Metric Stock Sector Median
P/E -2796.8 -1.5
P/B — 1.6
ROE % — -53.3
Net Margin % 22481.7 -41.5
Rev Growth 5Y % — 1.8
D/E — 0.3

All Fundamental Metrics
Growth
Revenue Growth (1Y) -94.06% Revenue Growth (3Y) -94.61%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) -158.0 Net Income (TTM) -35,521.0
ROE N/A ROA -15.06%
Gross Margin -39503.16% Operating Margin 38238.61%
Net Margin 22481.65% Free Cash Flow (TTM) -22,832.0
ROIC -25.94% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio N/A
Interest Coverage -4.11 Asset Turnover 0.00
Working Capital N/A Tangible Book Value -94,823
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -2796.84 Forward P/E N/A
P/B Ratio N/A P/S Ratio -628775.29
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -0.02%
Market Cap 99.35 M Enterprise Value 99.35 M
Per Share
EPS (Diluted TTM) 0.00 Revenue / Share 0.00
FCF / Share 0.00 OCF / Share 0.00
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 64.28%
SBC-Adj. FCF N/A Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2024 FY2023 FY2022 FY2021 FY2020
Revenue 139.0 2,340.0 47,800.0 15,967.0 0.0
Net Income -131,498.0 -116,895.0 -985,097.0 -116,981.0 -6,324.0
EPS (Diluted) 0.00 — — — —
Gross Profit 64.0 1,108.0 25,186.0 8,388.0 0.0
Operating Income -123,098.0 -116,895.0 -985,105.0 — —
EBITDA — — — — —
R&D Expenses — — — — —
SG&A Expenses — — — 126,655.0 6,368.0
D&A — — — — —
Interest Expense 8,400.0 — — 0.0 0.0
Income Tax 0.0 0.0 0.0 0.0 0.0

Balance Sheet

Annual, most recent first
Metric FY2024 FY2023 FY2022 FY2021 FY2020
Total Assets 224,192.0 228,057.0 248,400.0 460,979.0 248,569.0
Total Liabilities 271,433.0 143,334.0 46,782.0 159,266.0 0.0
Shareholders' Equity -47,241.0 84,723.0 201,618.0 301,713.0 248,569.0
Total Debt 173,985.0 — — — —
Cash & Equivalents — — 45,996.0 213,556.0 248,569.0
Current Assets — — — — —
Current Liabilities — — — 159,266.0 0.0